Jin Xu

Dr. Jin Xu


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Toxicology Letters
Verified
Journal Article
Closed access
JXJin Xu
Jin Xu
LJLin-Dan Ji
Lin-Dan Ji
LXLi-Hong Xu
Li-Hong Xu

1 March 2019 in Toxicon
Verified
Journal Article
Closed access
LFLing-Ling Fu
Ling-Ling Fu
XZXiao-Yu Zhao
Xiao-Yu Zhao
LJLin-Dan Ji
Lin-Dan Ji
JXJin Xu
Jin Xu

1 July 2015 in Toxicon
Verified
Journal Article
Closed access
MZMi Zhou
Mi Zhou
WTWei-Wei Tu
Wei-Wei Tu
JXJin Xu
Jin Xu

1 March 2010 in Journal Of Hypertension
Verified
Journal Article
Closed access
NUNingbo University
Ningbo University
LZLi-Na Zhang
Li-Na Zhang
PSPeng Shen
Peng Shen
PWPing Wang
Ping Wang
YZYue-Miao Zhang
Yue-Miao Zhang
JXJin Xu
Jin Xu
The polymorphisms of angiotensinogen (AGT) and angiotensin-converting enzyme (ACE) genes have been linked to increased risk of essential hypertension in multiple populations, but the results were inconsistent. To evaluate the associations of these polymorphisms with essential hypertension, we carried out a meta-analysis of the association studies within Han Chinese population. In this study, we reviewed two most commonly investigated polymorphisms, AGT M235T and ACE I/D, and provided summary estimates regarding their associations with essential hypertension. PubMed and China Biological Medicine Database were searched, and a total of 71 studies (31 studies for AGT M235T and 40 studies for ACE I/D) comprising 10 547 essential hypertension patients and 9217 controls from 23 provinces and special districts in China were finally included in this study. Statistically significant associations with essential hypertension were identified for TT genotype of AGT M235T polymorphism (odds ratio 1.54, 95% confidence interval 1.16-2.03, P = 0.002) and DD genotype of ACE I/D polymorphism (odds ratio 1.61, 95% confidence interval 1.32-1.98, P < 0.0001). Under dominant, recessive, and additive genetic models, positive associations were also found. The heterogeneity existed among the studies (P < 0.05), whereas the publication bias did not exist in both AGT analysis (P = 0.052) and ACE analysis (P = 0.103). The present meta-analysis suggests that AGT M235T and ACE I/D modulate the risk of essential hypertension in Han Chinese population.

1 January 2017 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
LLLin Luo
Lin Luo
WZWen-Hua Zhou
Wen-Hua Zhou
JCJiang-Jia Cai
Jiang-Jia Cai
MFMei Feng
Mei Feng
MZMi Zhou
Mi Zhou
NUNingbo University
Ningbo University
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus (DM). It is not diagnosed or managed properly in the majority of patients because its pathogenesis remains controversial. In this study, human whole genome microarrays identified 2898 and 4493 differentially expressed genes (DEGs) in DM and DPN patients, respectively. A further KEGG pathway analysis indicated that DPN and DM share four pathways, including apoptosis, B cell receptor signaling pathway, endocytosis, and Toll-like receptor signaling pathway. The DEGs identified through comparison of DPN and DM were significantly enriched in MAPK signaling pathway, NOD-like receptor signaling pathway, and neurotrophin signaling pathway, while the “neurotrophin-MAPK signaling pathway” was notably downregulated. Seven DEGs from the neurotrophin-MAPK signaling pathway were validated in additional 78 samples, and the results confirmed the initial microarray findings. These findings demonstrated that downregulation of the neurotrophin-MAPK signaling pathway may be the major mechanism of DPN pathogenesis, thus providing a potential approach for DPN treatment.

2 January 2025 in Annals of Medicine
Verified
Journal Article
Open access
HLHongyi Liu
Hongyi Liu
HZHui Zhu
Hui Zhu
QLQinkang Lu
Qinkang Lu
WYWen Ye
Wen Ye
THTao Huang
Tao Huang
NUNingbo University
Ningbo University
This study aimed to assess the associations between multidimensional sleep features and type 2 diabetes mellitus (T2DM). We conducted a systematic search across the PubMed, Embase, Web of Science, and Scopus databases for observational studies examining the association between nighttime sleep duration, nighttime sleep quality, sleep chronotype, and daytime napping with type 2 diabetes mellitus (T2DM), up to October 1, 2024. If I2 < 50%, a combined analysis was performed based on a fixed-effects model, and vice versa, using a random-effects model. Our analysis revealed that a nighttime sleep duration of less than 7 h (odds ratio [OR] = 1.18; 95% CI = 1.13, 1.23) or more than 8 h (OR = 1.13; 95% CI = 1.09, 1.18) significantly increased the risk of T2DM. Additionally, poor sleep quality (OR = 1.50; 95% CI = 1.30, 1.72) and evening chronotype (OR = 1.59; 95% CI = 1.18, 2.13) were associated with a notably greater risk of developing T2DM. Daytime napping lasting more than 30 min augments the risk of T2DM by 7-20%. Interactively, the incidence of T2DM was most significantly elevated among individuals with poor sleep quality and nighttime sleep duration of more than 8 h (OR = 2.15; 95% CI = 1.19, 3.91). A U-shaped relationship was observed between sleep duration and type 2 diabetes mellitus (T2DM), with the lowest risk occurring at a sleep duration of 7 to 8 h. Additionally, poor sleep quality, evening chronotypes, and daytime napping exceeding 30 min emerged as potential risk factors for T2DM. These high-risk sleep characteristics interacted with one another, amplifying the overall risk of developing the disease.